Chiasma Inc (CHMA1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark J. Fitzpatrick
Employees:
18
460 TOTTEN POND ROAD, SUITE 530, WALTHAM, MA 02451
617-928-5300

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Chiasma, Inc. operates as a pharmaceutical company, which engages in developing and commercializing oral forms of therapies that are available by injection. Its products include octreotide capsules and clinical trials. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin on April 12, 2001 and is headquartered in Waltham, MA.

Data derived from most recent annual or quarterly report
Market Cap 217.682 Million Shares Outstanding57.894 Million Avg 30-day Volume 708.631 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue64.9048 Debt to Equity0.0983 EBITDA-72.154 Million
Price to Book Value3.1371 Operating Margin-2408.6469 Enterprise Value87.788 Million
Current Ratio7.912 EPS Growth0 Quick Ratio6.701
1 Yr BETA 0.6234 52-week High/Low 5.74 / 2.77 Profit Margin-2968.3498
Operating Cash Flow Growth-110.2794 Altman Z-Score-2.6912 Free Cash Flow to Firm -12.421 Million
View SEC Filings from CHMA1 instead.

View recent insider trading info

Funds Holding CHMA1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CHMA1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2021-08-05:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-03:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-07-02:
    Item 8.01: Other Events
  • 8-K: filed on 2021-06-22:
    Item 8.01: Other Events
  • 8-K: filed on 2021-05-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-05:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-03-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-01-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-01-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    THERO JOHN F

    • Director
    0 2021-08-05 0

    STACK DAVID M

    • Director
    0 2021-08-05 0

    SCARLETT JOHN A

    • Director
    0 2021-08-05 0

    STONEPINE CAPITAL, L.P.

    • 10% Owner
    0 2021-08-05 0

    FOLEY TODD

    • Director
    0 2021-08-05 0

    MINICK SCOTT

    • Director
    0 2021-08-05 0

    MAMLUK RONI

    • Director
    0 2021-08-05 0

    GEESAMAN BARD

    • Director
    0 2021-08-05 0

    VARADAN ANAND EVP, CHIEF COMMERICAL OFFICER

    • Officer
    0 2021-08-05 0

    ENAMAIT DREW VP, FIN & ADMIN, PAO

    • Officer
    0 2021-08-05 0

    LUDLAM WILLIAM SEE REMARKS

    • Officer
    0 2021-08-05 0

    KANNAN RAJ CEO AND PRESIDENT

    • Officer
    • Director
    0 2021-08-05 0

    GIGUERE LEE GENERAL COUNSEL

    • Officer
    0 2021-08-05 0

    DOYLE JOHN BRENDAN CHIEF FINANCIAL OFFICER

    • Officer
    0 2021-08-05 0

    STONEPINE CAPITAL MANAGEMENT, LLC

    • 10% Owner
    6,770,000 2021-05-06 0

    FITZPATRICK MARK J. PRESIDENT

    • Officer
    19,612 2020-12-04 0

    GADICKE ANSBERT

    • Director
    0 2016-06-09 0

    TOBIN JAMES R

    • Director
    0 2016-06-09 0

    LEUCHTENBERGER MARK CEO, PRESIDENT

    • Officer
    • Director
    0 2016-02-10 0

    MCCARTHY TARA GENERAL COUNSEL AND SECRETARY

    • Officer
    0 2016-02-01 0

    MPM BIOVENTURES IV QP LP

    EVNIN LUKE

    SCOPA JAMES PAUL

    KAILIAN VAUGHN M

    MPM ASSET MANAGEMENT INVESTORS BV4 LLC

    MPM BIO IV NVS STRATEGIC FUND LP

    MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

    MPM BIOVENTURES IV GP LLC

    MPM BIOVENTURES IV LLC

    • 10% Owner
    5,681,544 2015-07-21 0

    7-MED HEALTH VENTURES LP

    WERTHEIMER RUTH

    • 10% Owner
    1,709,932 2015-07-21 0

    MILES VINCENT J

    • Director
    • 10% Owner
    0 2015-07-15 0

    ORLEV CHAIME SEE REMARKS

    • Officer
    0 2015-07-15 0

    ABINGWORTH LLP

    • 10% Owner
    0 2015-07-15 0

    GLOBEWAYS HOLDINGS LTD

    • 10% Owner
    0 2015-07-15 0

    GLOBEWAYS HOLDINGS LTD

    LJ SKYE TRUSTEES LTD.

    F2 CAPITAL I 2014 LTD

    • 10% Owner
    0 2015-07-15 0

    DROR BRANDWEIN

    • Director
    0 2015-07-15 0

    7-MED HEALTH VENTURES LP

    • 10% Owner
    273,762 2015-07-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CHIASMA INC CHMA 2021-08-05 22:15:04 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 21:45:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 21:15:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 20:45:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 20:15:04 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 19:45:04 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 19:15:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 18:45:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 18:15:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 17:45:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 17:15:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 16:45:02 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 16:15:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 15:45:03 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 15:15:02 UTC -1.1965 1.2765 1700000
    CHIASMA INC CHMA 2021-08-05 14:45:02 UTC -1.2344 1.3144 1700000
    CHIASMA INC CHMA 2021-08-05 14:15:04 UTC -1.2344 1.3144 1700000
    CHIASMA INC CHMA 2021-08-05 13:45:04 UTC -1.2344 1.3144 1700000
    CHIASMA INC CHMA 2021-08-05 13:15:03 UTC -1.2344 1.3144 1700000
    CHIASMA INC CHMA 2021-08-05 12:45:03 UTC -1.2344 1.3144 1700000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments